FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019439141> ?p ?o ?g. }

• W2019439141 endingPage "515" @default.
• W2019439141 startingPage "509" @default.
• W2019439141 abstract "The aim of this prospective, randomised, open-label, blinded-end point study was to compare the efficacy and safety of eplerenone versus spironolactone in patients with bilateral idiopathic hyperaldosteronism (IHA). After a 2-week washout period, 34 patients with IHA were assigned to receive either spironolactone 25 mg b.i.d. (n = 17) or eplerenone 25 mg b.i.d. (n = 17) for 24 weeks. If the patients' blood pressure (BP) was not < 140/90 mmHg, the doses were gradually increased up to 400 mg for spironolactone and 200 mg for eplerenone. If the patients' BP remained uncontrolled, a daily dose of hydrochlorothiazide 12.5 mg was added at week 16. The primary outcome was the percentage of patients with BP < 140/90 mmHg at 16 weeks (i.e., with aldosterone antagonist monotherapy). The patients' BP was normalised in 13 out of 17 (76.5%) and 14 out of 17 (82.4%) patients in the spironolactone and eplerenone groups, respectively (p = 1.00). Systolic BP decreased more rapidly with eplerenone. Serum potassium levels were normalised (> 3.5 mmol/l) in all patients at 4 weeks. Mild hyperkalaemia was observed in two patients receiving 400 mg of spironolactone and in three patients receiving 150 mg of eplerenone. Two patients presented with bilateral painful gynaecomastia at the end of week 16 while receiving 400 mg of spironolactone. Switching spironolactone to 150 mg of eplerenone daily resulted in resolution of gynaecomastia and also maintained BP control. At the end of the study, 19 patients were on eplerenone and 15 were on spironolactone. However, this did not affect the primary end point, because the switch from spironolactone to eplerenone (in two patients) occurred at the end of week 16. It was concluded that eplerenone was as effective as spironolactone in reducing BP in patients with IHA. The risk of mild hyperkalaemia was similar with both drugs." @default.
• W2019439141 created "2016-06-24" @default.
• W2019439141 creator A5004312980 @default.
• W2019439141 creator A5005580657 @default.
• W2019439141 creator A5033545563 @default.
• W2019439141 creator A5058561558 @default.
• W2019439141 creator A5061448658 @default.
• W2019439141 creator A5068639798 @default.
• W2019439141 creator A5076157401 @default.
• W2019439141 creator A5090081265 @default.
• W2019439141 date "2008-03-01" @default.
• W2019439141 modified "2023-09-26" @default.
• W2019439141 title "Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism" @default.
• W2019439141 cites W1558440797 @default.
• W2019439141 cites W1814252166 @default.
• W2019439141 cites W1977117807 @default.
• W2019439141 cites W1980094514 @default.
• W2019439141 cites W1984388924 @default.
• W2019439141 cites W1984717781 @default.
• W2019439141 cites W1990887256 @default.
• W2019439141 cites W1998463406 @default.
• W2019439141 cites W2003989747 @default.
• W2019439141 cites W2012417977 @default.
• W2019439141 cites W2019216135 @default.
• W2019439141 cites W2024885055 @default.
• W2019439141 cites W2034867134 @default.
• W2019439141 cites W2042552892 @default.
• W2019439141 cites W2047458689 @default.
• W2019439141 cites W2047908219 @default.
• W2019439141 cites W2051617480 @default.
• W2019439141 cites W2058801122 @default.
• W2019439141 cites W2072074888 @default.
• W2019439141 cites W2075460104 @default.
• W2019439141 cites W2078741210 @default.
• W2019439141 cites W2086392932 @default.
• W2019439141 cites W2095527951 @default.
• W2019439141 cites W2097451187 @default.
• W2019439141 cites W2101785330 @default.
• W2019439141 cites W2103340325 @default.
• W2019439141 cites W2116087989 @default.
• W2019439141 cites W2123778248 @default.
• W2019439141 cites W2125226019 @default.
• W2019439141 cites W2140078175 @default.
• W2019439141 cites W2142803942 @default.
• W2019439141 cites W2148671035 @default.
• W2019439141 cites W2152094259 @default.
• W2019439141 cites W2158828981 @default.
• W2019439141 cites W2165141146 @default.
• W2019439141 cites W4235206191 @default.
• W2019439141 cites W4242669072 @default.
• W2019439141 doi "https://doi.org/10.1517/14656566.9.4.509" @default.
• W2019439141 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18312153" @default.
• W2019439141 hasPublicationYear "2008" @default.
• W2019439141 type Work @default.
• W2019439141 sameAs 2019439141 @default.
• W2019439141 citedByCount "112" @default.
• W2019439141 countsByYear W20194391412012 @default.
• W2019439141 countsByYear W20194391412013 @default.
• W2019439141 countsByYear W20194391412014 @default.
• W2019439141 countsByYear W20194391412015 @default.
• W2019439141 countsByYear W20194391412016 @default.
• W2019439141 countsByYear W20194391412017 @default.
• W2019439141 countsByYear W20194391412018 @default.
• W2019439141 countsByYear W20194391412019 @default.
• W2019439141 countsByYear W20194391412020 @default.
• W2019439141 countsByYear W20194391412021 @default.
• W2019439141 countsByYear W20194391412022 @default.
• W2019439141 countsByYear W20194391412023 @default.
• W2019439141 crossrefType "journal-article" @default.
• W2019439141 hasAuthorship W2019439141A5004312980 @default.
• W2019439141 hasAuthorship W2019439141A5005580657 @default.
• W2019439141 hasAuthorship W2019439141A5033545563 @default.
• W2019439141 hasAuthorship W2019439141A5058561558 @default.
• W2019439141 hasAuthorship W2019439141A5061448658 @default.
• W2019439141 hasAuthorship W2019439141A5068639798 @default.
• W2019439141 hasAuthorship W2019439141A5076157401 @default.
• W2019439141 hasAuthorship W2019439141A5090081265 @default.
• W2019439141 hasConcept C126322002 @default.
• W2019439141 hasConcept C126894567 @default.
• W2019439141 hasConcept C134018914 @default.
• W2019439141 hasConcept C189135053 @default.
• W2019439141 hasConcept C2776292634 @default.
• W2019439141 hasConcept C2776379505 @default.
• W2019439141 hasConcept C2778525890 @default.
• W2019439141 hasConcept C2780072264 @default.
• W2019439141 hasConcept C71924100 @default.
• W2019439141 hasConcept C90924648 @default.
• W2019439141 hasConceptScore W2019439141C126322002 @default.
• W2019439141 hasConceptScore W2019439141C126894567 @default.
• W2019439141 hasConceptScore W2019439141C134018914 @default.
• W2019439141 hasConceptScore W2019439141C189135053 @default.
• W2019439141 hasConceptScore W2019439141C2776292634 @default.
• W2019439141 hasConceptScore W2019439141C2776379505 @default.
• W2019439141 hasConceptScore W2019439141C2778525890 @default.
• W2019439141 hasConceptScore W2019439141C2780072264 @default.
• W2019439141 hasConceptScore W2019439141C71924100 @default.
• W2019439141 hasConceptScore W2019439141C90924648 @default.
• W2019439141 hasIssue "4" @default.

• next